Amanote Research
Register
Sign In
Delivery of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers for Prostate Cancer
Drug Design, Development and Therapy
- New Zealand
doi 10.2147/dddt.s210949
Full Text
Open PDF
Abstract
Available in
full text
Categories
Drug Discovery
Pharmacology
Pharmaceutical Science
Date
November 1, 2019
Authors
Qi Ma
Wei Qian
Wei Tao
Yanling Zhou
Boxin Xue
Publisher
Informa UK Limited
Related search
Growth Kinetics of CD133-positive Prostate Cancer Cells
Prostate
Oncology
Urology
Tumor-Targeted Drug Delivery With Aptamers
Current Medicinal Chemistry
Organic Chemistry
Biochemistry
Drug Discovery
Molecular Medicine
Pharmacology
Controlled Delivery of Dopamine Hydrochloride Using Surface Modified Carbon Dots for Neuro Diseases
Biophysical Journal
Biophysics
Delivery of Anti-miRNA for Triple Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting to Stem Cell Marker CD133
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
In VitroSelection of Modified RNA Aptamers Against CD44 Cancer Stem Cell Marker
Nucleic Acid Therapeutics
Biochemistry
Molecular Medicine
Drug Discovery
Genetics
Molecular Biology
Potential Advantages of a Novel Chitosan-N-Acetylcysteine Surface Modified Nanostructured Lipid Carrier on the Performance of Ophthalmic Delivery of Curcumin
Scientific Reports
Multidisciplinary
Aptamers for Targeted Delivery: Current Challenges and Future Opportunities
Gene-Modified Bone Marrow Cell Therapy for Prostate Cancer
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Effect of CD133 Overexpression on Bone Metastasis in Prostate Cancer Cell Line LNCaP
Oncology Letters
Cancer Research
Oncology
